PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1126476
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1126476
Contact us about how to customize the report with add-on data.
According to Stratistics MRC, the Global Glucose Analysis Tubes Market is accounted for $456.2 million in 2022 and is expected to reach $711.95 million by 2028 growing at a CAGR of 7.7% during the forecast period. A glucose analysis tubes is mostly a diagnostic test of the blood that checks for diabetes by measuring the level of glucose in a person's blood.
According to WHO, in 2019, there were 254 million older adults aged 60 and above in the country and 176 million older adults aged 65 and above. Thus, glucose analysis tube manufacturers have a great opportunity to grow in the country over the forecast period.
Rising prevalence of diabetes across
The high pervasiveness of diabetes across the world is one element supporting development in the worldwide market. Change in dietary patterns, hunger, hereditary transformation, etc. Additional, ascend in mindfulness among the client with respect to taking care of oneself test strips for successful observing of blood sugar level lifts the interest for blood glucose test strips in the locale. Regular monitoring of diabetes through glucose analysis and healthy lifestyle and eating habits can help in reducing the risk of diabetes. Mechanical progression in the medical services industry is another element that could expand the development of the worldwide market. Administrative bodies are assisting makers with consolidating very good quality innovation in their items. This is likewise driving the worldwide market.
Due to unnecessary cost associated to the test strips is one of the critical limitations of the worldwide market. It builds the general expense of treatment altogether as a diabetic patent expects 4 to 5strips in the day for powerful observing of their blood glucose. Hence, the vast majority of the patients are turning towards the more reasonable nonexclusive strips.
There is a rising trend toward improvements in blood collection. Two firms won US FDA 510(k) clearances for blood collection devices recently-a push-button device from Seventh Sense called TAP, and a needle-free device from Velano Vascular called Pivo. Innovative hematology-tube designs have been introduced to support capillary-blood collection for reducing the risks of collection and processing errors in DVA patients. Besides this, a vein illumination and visualization technique-vein finder, a recent addition to safe blood collection procedures-is used to assist healthcare professionals in finding a good vein for venipuncture. The device illuminates the veins beneath the skin using ultrasound or infrared technology and facilitates easy vein access, thus reducing the need for repeated venipuncture. Hence it creates ample opportunities for the market growth.
Difficulties of storage and shipping
Storage and shipping whole blood samples poses significant challenges and costs. Once collected, whole blood must be used instantly or stored and preserved under strict temperature and environmental conditions for analysis or other applications. The characteristics of blood samples begin to change within hours of collection if not refrigerated or frozen. Keeping their constancy is vital since blood components begin to degrade immediately; extended exposure to ambient temperatures can dramatically affect the outcome of any analysis on such samples. Therefore, medical organizations around the world have created guidelines for their storage, packaging, and shipping.
Impact of Covid- 19
COVID-19 is anticipated to have a positive impact on the market for glucose analysis tubes. It is owing to increasing demand for diagnosis and testing during the pandemic phase. The diagnostic industry is the one with the highest demand during the coronavirus outbreak. With increase of the coronavirus crisis, healthcare providers shifted their practice and purchasing priorities to meet the demands of a pandemic. Also, it was seen that many people experienced elevated blood glucose levels post COVID-19 infection. Regular monitoring in such cases, thus, increased demand for these tubes at diagnostic centers.
The Polyethylene PET/Plastic segment is expected to be the largest during the forecast period
The Polyethylene PET/Plastic segment is expected to be the largest during the forecast period, owing to numerous benefits such as it being lightweight and less expensive than glass tubes. PET/Plastic strong, break-resistant, and can be as clear as glass bottles or jars. PET makes an excellent choice as a material in many industries. Factors such as its chemical resistance, strength-to-weight ratio, shatterproof properties, and low-cost to product make it an accessible solution for consumable product packaging. Furthermore, the toughness of plastic is more as compared to glass. Thus, this segment is expected to create multiple opportunity for manufactures.
The Hospitals segment is expected to have the highest CAGR during the forecast period
The Hospitals segment is expected to have the highest CAGR during the forecast period. The growing prevalence of transferrable diseases and the increase in the number of trauma cases, as well as C-sections and organ transplants, have ensured the demand for blood collection equipment and devices in hospital facilities.
Region with highest share:
North America is projected to hold the largest market share during the forecast period The factor attributed to the growth of this market is driven by alteration or changes in lifestyle and unhealthy eating habits, and presence of key players in the U.S. actors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the province are motivating the growth of the market in North America.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, due to factors like a boost in government backing and the surging progress in blood collection technology in the Asia-Pacific province. The growing population of the elderly and the increasing need for blood transfusion for the treatment of distinct hematological ailments requiring the application of EDTA tubes are further fuelling the progress of the Market in the Asia-Pacific region.
Key players in the market
Some of the key players profiled in the Glucose Analysis Tubes Market include Becton, Dickinson, and Company, Greiner Bio-One International GmbH, Guangzhou Improve Medical Instruments Co.,Ltd, AB Medical Inc.,, SARSTEDT AG & Co.KG, InterVac Technology, Cardinal Health, Inc., Poly Medicure Ltd., FL Medical, CHENGDU RICH SCIENCE INDUSTRY CO., LTD., Sekisui Medical Co., Ltd, APTACA spa, Hindustan Syringes & Medical Devices, Biosigma S.p.A.
In February 2021: Greiner Bio-One introduced the Vacuette FC Mix Tube for glucose analysis.
In March 2018: Becton, Dickinson, and Company (BD) upgraded its instructions for its BD vacutainer tubes as a part of its quality process, which ensures the appropriate use of these tubes.
End Users Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Table16 North America Glucose Analysis Tubes Market Outlook, By Sodium Fluoride (2020-2028) (US $MN)